NOVELLI, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 4.614
Totale 4.614
Nazione #
IT - Italia 4.614
Totale 4.614
Città #
Genova 3.704
Rapallo 541
Genoa 280
Vado Ligure 81
Bordighera 8
Totale 4.614
Nome #
null 200
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 187
Antiviral activity of benzimidazole derivatives. II Antiviral activity of 2-phenylbenzimidazole derivatives. 159
Organometallic compounds in oncology: implications of novel organotins as antitumor agents 135
Gold(I) complexes as antimicrobial agents 133
Acridine derivatives as anti-BVDV agents 133
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 131
Formation of basic compounds during the indole cyclization of ketone phenylhydrazones 130
Novel celecoxib analogues inhibit glial production of prostaglandinE2, nitric oxide, and oxygen radicals reverting the neuroinflammatoryresponses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide 128
1-(Arylalkyl)quinolizidine derivatives and thio-isosteric analogues as ligands for sigma receptors 122
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells 120
Spiro[1,2,4-benzotriazine-3(4H),4’-(1’-substituted)-piperidines] and related compounds as ligands for sigma receptors 119
4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity 118
Synthesis and pharmacological evaluation of some thiolupinine derivatives 116
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation 112
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles 111
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines 110
Quinolizidine derivatives with antitubercular activity 110
Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and beta-Amyloid (Abeta) Aggregation 108
(+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype 107
Synthesis and biological activity of gold and tin compounds in ovarian cancer cells 105
Triorganotin compounds as antimicrobial agents 103
In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo 103
Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity 103
Novel Sigma Binding Site Ligands as Inhibitors of Cell Proliferation in Breast Cancer 101
New arylsparteine derivatives as positive inotropic drugs 100
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease 96
On the self-condensation of aminoguanidine leading to 1,1,4,10,10-pentaamino-2,3,5,6,8,9-hexaazadeca-1,3,5,7,9-pentaene (Structure elucidation through X-ray powder diffraction) 95
null 94
Preparation and pharmacological activities of spiro[3,4-dihydro-6/7-R-1,2,4-benzotriazine-3,4'-(1'-substituted)piperidines] 93
Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors 93
Synthesis and biological investigations of 1-(tetrahydropyran-2'-yl)- and 1-(tetrahydrofuran-2'-yl)-benzimidazoles and 1/2-(tetrahydropyran-2'-yl)- and 1/2-(tetrahydro-furan-2'-yl)benzotriazoles 91
Quinolizidine derivatives as ligands for sigma receptors 87
Antitubercular and antiprotozoal activities of quinolizidinyl/pyrrolizidinylalkyliminophenazines 85
Synthesis and preliminary pharmacological evaluation of 3-[2-(1-aryl-piperazin-4-yl)ethyl]-3,4-dihydro-3-methyl-6-R-1,2,4-benzotriazines 82
Synthesis and biological investigation of 2-(tetrahydropyran-2'-yl) and 2-(tetrahydrofuran-2'-yl)-benzimidazoles 77
Synthesis and antiplasmodial activity of novel chloroquine analogues with bulky basic side chains 77
Inhibitory properties of triethylphenosphine goldlupinylsulfide in adjuvant-induced arthritis in rats 76
Antitumor activity of a new o rally active organotin compound: a preliminare study in murine tumor models 73
Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound 68
Quinolizidinyl derivatives of bi- and tricyclic systems as AChE/BchE and beta-amyloid aggregation inhibitors, 67
Novel organotins as antitumor agents 66
Thiolupinine and some derivatives of pharmacological interest 60
Preparazione e attività farmacologica di ammido-derivati 3-metil-3,4-diidro benzo e pirido-1,2,4-triazin-3-acetici 39
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS 32
Antiproliferative activity and interactions with cell-cycle related proteins of the organotin compound triethyltin(IV)lupinylsulfide hydrochloride 30
Totale 4.685
Categoria #
all - tutte 13.581
article - articoli 13.158
book - libri 0
conference - conferenze 423
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.287 0 0 73 87 122 136 200 80 185 208 144 52
2020/2021322 24 22 68 16 11 31 15 21 31 33 24 26
2021/2022607 19 37 42 87 13 37 31 148 13 54 28 98
2022/2023614 47 20 12 56 114 119 2 53 91 1 93 6
2023/2024209 11 40 3 33 11 48 5 11 5 6 15 21
2024/202587 13 61 13 0 0 0 0 0 0 0 0 0
Totale 4.685